Article
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).
The Journal of infectious diseases - 15 Mar 2005
Sisowath Christin, Strömberg Johan, Mårtensson Andreas, Msellem Mwinyi, Obondo Christine, Björkman Anders, Gil José P
Abstract excerpt
Artemisinin derivative-based combination therapy is expected to suppress the development of Plasmodium falciparum drug resistance in Africa. We have performed an artemether-lumefantrine (Coartem; Novartis) follow-up clinical trial in Zanzibar, in which pfcrt K76T and pfmdr1 N86Y frequencies were determined before drug administration and in all recurrent parasites during a follow-up period of 42 days. A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
